{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Jiao L"],"funding":["Natural Science Foundation of Liaoning Province"],"pagination":["147-152"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8862018"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["32(2)"],"pubmed_abstract":["<h4>Objective</h4>To assess the strategy and value of centralized surveillance of hydatidiform mole at a regional hospital in China and to investigate the necessity of prophylactic chemotherapy for high-risk complete hydatidiform mole.<h4>Methods</h4>Between February 2013 and February 2020, all women with hydatidiform mole in Dalian Women's and Children's Medical Center (Group) were registered for surveillance and treatment when indicated. Women with complete hydatidiform mole were categorized into low-risk and high-risk groups according to the criteria from Song Hongzhao's trophoblastic neoplasia. Outcomes and treatments were analyzed retrospectively.<h4>Results</h4>In total, 703 women with hydatidiform mole were registered for surveillance with a follow-up rate of 97.9% (688/703). 680 wo"],"journal":["International journal of gynecological cancer : official journal of the International Gynecological Cancer Society"],"pubmed_title":["Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China."],"pmcid":["PMC8862018"],"funding_grant_id":["2020-MS-335"],"pubmed_authors":["Zhang W","Jiang J","Jiao L","Xiang Y","Wang X","Wang Y","Zhu C"],"additional_accession":[]},"is_claimable":false,"name":"Centralized surveillance of hydatidiform mole: 7-year experience from a regional hospital in China.","description":"<h4>Objective</h4>To assess the strategy and value of centralized surveillance of hydatidiform mole at a regional hospital in China and to investigate the necessity of prophylactic chemotherapy for high-risk complete hydatidiform mole.<h4>Methods</h4>Between February 2013 and February 2020, all women with hydatidiform mole in Dalian Women's and Children's Medical Center (Group) were registered for surveillance and treatment when indicated. Women with complete hydatidiform mole were categorized into low-risk and high-risk groups according to the criteria from Song Hongzhao's trophoblastic neoplasia. Outcomes and treatments were analyzed retrospectively.<h4>Results</h4>In total, 703 women with hydatidiform mole were registered for surveillance with a follow-up rate of 97.9% (688/703). 680 wo","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Feb","modification":"2025-05-29T19:46:38.62Z","creation":"2025-04-05T20:55:11.747Z"},"accession":"S-EPMC8862018","cross_references":{"pubmed":["34799419"],"doi":["10.1136/ijgc-2021-002797"]}}